Tsumura & Co. (4540.T)

JPY 4759.0

(-0.69%)

Gross Profit Summary of Tsumura & Co.

  • Tsumura & Co.'s latest annual gross profit in 2023 was 68.81 Billion JPY , up 0.78% from previous year.
  • Tsumura & Co.'s latest quarterly gross profit in 2024 Q1 was 22.83 Billion JPY , up 65.95% from previous quarter.
  • Tsumura & Co. reported a annual gross profit of 68.28 Billion JPY in annual gross profit 2022, up 2.73% from previous year.
  • Tsumura & Co. reported a annual gross profit of 66.46 Billion JPY in annual gross profit 2021, down -11.3% from previous year.
  • Tsumura & Co. reported a quarterly gross profit of 16.69 Billion JPY for 2023 Q1, up 6.19% from previous quarter.
  • Tsumura & Co. reported a quarterly gross profit of 13.75 Billion JPY for 2023 Q4, down -33.32% from previous quarter.

Annual Gross Profit Chart of Tsumura & Co. (2023 - 2003)

Historical Annual Gross Profit of Tsumura & Co. (2023 - 2003)

Year Gross Profit Gross Profit Growth
2023 68.81 Billion JPY 0.78%
2022 68.28 Billion JPY 2.73%
2021 66.46 Billion JPY -11.3%
2020 74.93 Billion JPY 3.35%
2019 72.5 Billion JPY 1.46%
2018 71.45 Billion JPY 4.66%
2017 68.27 Billion JPY 4.24%
2016 65.5 Billion JPY -3.06%
2015 67.57 Billion JPY -1.47%
2014 68.57 Billion JPY -3.77%
2013 71.26 Billion JPY 2.23%
2012 69.71 Billion JPY 6.42%
2011 65.5 Billion JPY 0.25%
2010 65.34 Billion JPY 4.69%
2009 62.41 Billion JPY 2.34%
2008 60.98 Billion JPY -3.49%
2007 63.19 Billion JPY 2.27%
2006 61.78 Billion JPY -1.01%
2005 62.41 Billion JPY 7.04%
2004 58.31 Billion JPY 3.17%
2003 56.52 Billion JPY 0.0%

Peer Gross Profit Comparison of Tsumura & Co.

Name Gross Profit Gross Profit Difference
Pharma Foods International Co., Ltd. 48.75 Billion JPY -41.157%
Takeda Pharmaceutical Company Limited 2184.96 Billion JPY 96.85%
Sumitomo Pharma Co., Ltd. 187.98 Billion JPY 63.392%
Shionogi & Co., Ltd. 369.08 Billion JPY 81.355%
Wakamoto Pharmaceutical Co.,Ltd. 3.54 Billion JPY -1843.517%
Nippon Shinyaku Co., Ltd. 97.01 Billion JPY 29.067%
Kaken Pharmaceutical Co., Ltd. 38.22 Billion JPY -80.046%
Eisai Co., Ltd. 586.41 Billion JPY 88.265%
Morishita Jintan Co., Ltd. 5.99 Billion JPY -1047.332%
Hisamitsu Pharmaceutical Co., Inc. 78.97 Billion JPY 12.858%
Mochida Pharmaceutical Co., Ltd. 52.07 Billion JPY -32.162%
Fuso Pharmaceutical Industries,Ltd. 13.51 Billion JPY -409.114%
Nippon Chemiphar Co., Ltd. 7.73 Billion JPY -789.338%
Kissei Pharmaceutical Co., Ltd. 37.34 Billion JPY -84.293%
Torii Pharmaceutical Co., Ltd. 24.79 Billion JPY -177.577%
Towa Pharmaceutical Co., Ltd. 81.38 Billion JPY 15.441%
Fuji Pharma Co., Ltd. 16.51 Billion JPY -316.694%
Zeria Pharmaceutical Co., Ltd. 50.18 Billion JPY -37.137%
KYORIN Holdings, Inc. 51.4 Billion JPY -33.885%
Taiko Pharmaceutical Co.,Ltd. 1.07 Billion JPY -6277.85%
Daito Pharmaceutical Co.,Ltd. 9.83 Billion JPY -599.431%
SymBio Pharmaceuticals Limited 4.41 Billion JPY -1460.117%
MedRx Co., Ltd 26 Million JPY -264580.769%
Mizuho Medy Co.,Ltd. 8.02 Billion JPY -757.456%
Solasia Pharma K.K. 337 Million JPY -20320.475%
Modalis Therapeutics Corporation -731 Thousand JPY 9414190.287%
ASKA Pharmaceutical Holdings Co.,Ltd. 30.66 Billion JPY -124.415%
Sawai Group Holdings Co., Ltd. 54.31 Billion JPY -26.69%
Cyfuse Biomedical K.K. 37.74 Million JPY -182225.668%
Toho Holdings Co., Ltd. 112.98 Billion JPY 39.092%
Koa Shoji Holdings Co.,Ltd. 6.63 Billion JPY -936.463%